Imad Shureiqi Selected Research

PPAR delta

1/2022	Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors.
1/2019	Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion.
1/2019	PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice.
5/2009	Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.
8/2003	The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Imad Shureiqi Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 12/2004
19	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 02/2002
18	Colonic Neoplasms (Colon Cancer) 01/2018 - 08/2003
17	Carcinogenesis 01/2022 - 08/2003
8	Inflammation (Inflammations) 01/2022 - 12/2006
4	Polyps 01/2022 - 07/2010
3	Obesity 10/2018 - 03/2013
3	Neoplasm Metastasis (Metastasis) 12/2017 - 10/2012
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2019
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022 - 01/2018
2	Insulin Resistance 10/2018 - 09/2015
1	Colonic Polyps 01/2022
1	Atherosclerosis 10/2018
1	Type 2 Diabetes Mellitus (MODY) 10/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Dyslipidemias (Dyslipidemia) 10/2018
1	Colitis 01/2017
1	Triple Negative Breast Neoplasms 09/2015
1	Breast Neoplasms (Breast Cancer) 09/2015
1	Colitis-Associated Neoplasms 06/2015
1	Hypoxia (Hypoxemia) 06/2014
1	Rectal Neoplasms (Rectal Cancer) 02/2014

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 12/2017 - 12/2005
5	AcidsIBA 01/2022 - 08/2003
5	PPAR deltaIBA 01/2022 - 08/2003
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018 - 03/2013
5	Messenger RNA (mRNA)IBA 06/2015 - 03/2007
4	Lipoxygenase (Lipoxygenase-1)IBA 01/2022 - 12/2005
4	LipidsIBA 01/2018 - 12/2006
4	AzoxymethaneIBA 01/2017 - 05/2009
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 01/2014
3	villinIBA 01/2022 - 04/2014
3	EicosanoidsIBA 09/2015 - 12/2006
3	Histone Deacetylase InhibitorsIBA 11/2008 - 12/2004
3	Pharmaceutical PreparationsIBA 05/2008 - 03/2007
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 03/2013
2	Linoleic Acid (Linoleate)IBA 01/2022 - 01/2020
2	13-hydroxy-9,11-octadecadienoic acidIBA 01/2022 - 07/2010
2	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 01/2022 - 10/2012
2	Leukotriene B4IBA 01/2022 - 07/2010
2	CateninsIBA 01/2020 - 01/2019
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 03/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014 - 05/2009
2	MethyltransferasesIBA 01/2014 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 06/2008
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2012 - 12/2006
2	Arachidonic Acid (Vitamin F)IBA 10/2012 - 12/2005
2	Histones (Histone)IBA 12/2011 - 11/2008
2	Small Interfering RNA (siRNA)IBA 06/2008 - 03/2007
2	Caspase 3 (Caspase-3)IBA 05/2008 - 05/2008
2	X-Linked Inhibitor of Apoptosis ProteinIBA 05/2008 - 05/2008
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2003 - 02/2002
1	Oleic Acid (Oleate)IBA 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 01/2022
1	Celecoxib (Celebrex)FDA Link 01/2022
1	GW 501516IBA 01/2019
1	CytokinesIBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	4- chloro- N- (2- ((5- trifluoromethyl- 2- pyridyl)sulfonyl)ethyl)benzamideIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Sulindac (Copal)FDA LinkGeneric 01/2018
1	Cyclooxygenase InhibitorsIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Ligases (Synthetase)IBA 06/2017
1	UbiquitinIBA 06/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	CarcinogensIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	LipoxinsIBA 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	VemurafenibIBA 12/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2016
1	Cetuximab (Erbitux)FDA Link 12/2016
1	LeptinIBA 09/2015
1	EstersIBA 09/2015
1	ClaudinsIBA 09/2015
1	Omacor FDA Link 09/2015
1	Docosahexaenoic AcidsIBA 09/2015
1	SuspensionsIBA 09/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2015
1	AdiponectinIBA 09/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2015
1	Interleukin-6 (Interleukin 6)IBA 06/2015
1	Cardiac GlycosidesIBA 04/2014
1	Adenosine Triphosphatases (ATPase)IBA 04/2014
1	oleandrinIBA 04/2014
1	Protein Isoforms (Isoforms)IBA 04/2014
1	Bevacizumab (Avastin)FDA Link 02/2014
1	Capecitabine (Xeloda)FDA Link 02/2014
1	hydrogen sulfite (bisulfite)IBA 01/2014

Therapy/Procedure

5	Therapeutics 12/2020 - 12/2004
2	Chemoprevention 01/2018 - 03/2011
1	Renal Dialysis (Hemodialysis) 12/2014
1	Radiotherapy 02/2014